Molecular characterisation of virulence graded field isolates of myxoma virus
© Dalton et al; licensee BioMed Central Ltd. 2010
Received: 30 December 2009
Accepted: 26 February 2010
Published: 26 February 2010
Myxoma virus (MV) has been endemic in Europe since shortly after its deliberate release in France in 1952. While the emergence of more resistant hosts and more transmissible and attenuated virus is well documented, there have been relatively few studies focused on the sequence changes incurred by the virus as it has adapted to its new host. In order to identify regions of variability within the MV genome to be used for phylogenetic studies and to try to investigate causes of MV strain attenuation we have molecularly characterised nine strains of MV isolated in Spain between the years 1992 and 1995 from wide ranging geographic locations and which had been previously graded for virulence by experimental infection of rabbits.
The findings reported here show the analysis of 16 genomic regions accounting for approximately 10% of the viral genomes. Of the 20 genes analysed 5 (M034L, M069L, M071L, M130R and M135R) were identical in all strains and 1 (M122R) contained only a single point mutation in an individual strain. Four genes (M002L/R, M009L, M036L and M017L) showed insertions or deletions that led to disruption of the ORFs.
The findings presented here provide valuable tools for strain differentiation and phylogenetic studies of MV isolates and some clues as to the reasons for virus attenuation in the field.
Myxoma virus (MV) causes myxomatosis in the European rabbit (Oryctolagus cuniculus). The disease is a recurrent problem in rabbit farms and in wild rabbit populations throughout Europe [1–4]. Due to the unique manner of its introduction into the European rabbit population, MV provides an excellent model for studying the coevolution of a virus and its host. The complex virus/host relationship has been shown to lead to the emergence of more transmissible/attenuated virus strains and more resistant hosts (for review see ). Such studies have been carried out using experimental rabbit infections, however, few studies have characterised the sequence changes incurred by the virus during adaptation to its new host [1, 6–10].
MV strains are classified into 5 virulence grades (I to V, I being most virulent and V the most attenuated) based on the mean survival time of rabbits after infection . Due to the large size of the viral genome (161.8 kb) restriction fragment length polymorphism (RFLP) analysis of purified viral genomes has been the traditional method for the molecular differentiation of MV strains [6, 11]. However, no correlation between RFLPs and attenuation has been demonstrated .
Recent studies of field strains of MV have focussed on sequencing genes or gene fragments, however, the majority of these strains have not been characterised for virulence in rabbits [1, 9]. Epidemiological studies on large numbers of virus isolates are essential to differentiate the types of circulating MV-isolates and to identify new emergent strains which might have different degrees of virulence.
Hampered by the large size of the viral genome, to date only two full-length genome sequences are available, strain Lausanne (Lu)  and strain 6918 . These data allowed the first direct comparison between two full-length MV genomes, one (Lu) being wild-type (wt) and the other (6918) being attenuated .
Strain 6918 was first isolated during field sampling of MV in Spain . In that study twenty isolates, collected from wide ranging locations between 1992 and 1995, were further characterized for their virulence grade and horizontal transmission in experimental infections of rabbits. These MV-isolates included a representative example of all five virulence grades providing an excellent starting biological material for molecular studies on MV strain differentiation and for the investigation of the molecular basis of virus attenuation in the field.
The aims of the study presented here were to molecularly characterise nine MV isolates  and to identify mutations that could be potential causes for virus attenuation. In carrying out this study we also aimed to identify genetic markers for the differentiation of MV isolates and to identify variable hotspots in the MV genomes therefore providing valuable tools for future epidemiological studies.
To accomplish these objectives preliminary RFLP analysis of purified full-length virus genomes and PCR-amplified terminal inverted repeats (TIR) regions were coupled with a comprehensive sequencing study of 16 genomic regions encompassing 20 genes (14 completely sequenced and 6 partially sequenced) and 7 intergenic regions. The sequenced regions covered approximately 10% of the virus genomes. The results of these analyses, together with the results from the published full sequence of the attenuated 6918 strain, are discussed with regard to MV strain differentiation, and potential causes for virus attenuation.
In order to identify regions of variability in the MV genome to be used for MV strain differentiation, phylogenetic studies and to investigate possible reasons for virus attenuation we endeavoured to molecularly characterise nine representative strains of MV from the 20 originally isolated in Spain between the years 1992 and 1995  from wide ranging geographic locations (see Additional file 1). The virus strains had previously been characterised for their transmissibility and virulence in rabbits, with each strain given a virulence grade A-E , these grades being exactly equivalent to the grades I-V previously designated by Fenner and Marshall (1957). The selected strains were representative of different levels of virulence: 87, 466, 2012 and 86 (grade A); 2788, 7514 and 1312 (grade B); 7411 (grade C) and strain 4604 (grade E), which corresponded to a naturally attenuated MV isolate (See Additional file 2). It should be mentioned that although strain 6918 (grade E) was not directly analyzed in the present study the published sequence data  from the relevant regions of this strain were analyzed together with those from the 9 isolates studied. This was done because strain 6918 was originally isolated and characterized, in terms of virulence and transmissibility, under the same conditions  as the strains studied in this paper.
Primers used for the amplification of genes analysed in this study.
Forward primer (5'-3') and genomic positionb
Reverse primer (5'-3') and genomic positionb
Amplicon size (bp)
Reason for inclusion
TNF receptor homolog
GGTCCGTGATTAATATTCG 2864 - 2882/158892-158910(c)
Mutations detected in field strains 
ER localized apoptosis regulator
RFLP (data not shown)
Virulence factor 
Kelch ring canal protein homolog
ACGTGGGAAGCCGATGTC AG 13413-13432
Mutation detected in strain 6918 
EGF-like growth Factor
GCGTGGGCACGTTGAACA CG 14180-14199
Integral membrane protein apoptosis regulator
Mutations detected in field strains 
CTCTCAGGTGTTGAGTACG G 35691-35710
Potential diagnostic PCR
Leucine zipper motif
GTTTTCTGCGGATGGATCT C 39333-39352
Mutation detected in strain 6918 
GAAGAAACAGACCGTGGA CAC 66714-66734
Mutation detected in strain 6918 
Immunodominant envelope protein
CTTATAGAATCTTTTCATA C 116882-116901
Gene function 
Virulence factor 
GATGCATCGATTAACACGT C 137761-137780
Virulence factor 
Complement control protein homolog
CTAGATCGCCTCCTCTCCA GC 140369-140389
Gene function 
The sequences of the investigated genomic regions included 7 intergenic sequences and 20 complete genes or gene fragments, representing approximately 10% of the viral genome.
The sequence data from the 9 MV field strains indicated that two of them (466 and 2012) although isolated in very distant places in Spain (Additional file 1) could not be differentiated from one another and should be considered, with the available sequence data, as a single virus haplotype. All the remaining strains could be distinguised from each other using the obtained sequence data. The MV field strain sequences corresponding to the 16 amplified regions were aligned and compared to the published 6918 sequences (also isolated in Spain) and to those from reference strain Lausanne (Lu). Five of the regions analysed (corresponding to genes or gene fragments M034, M069, M071, M130 and M135) were identical (data not shown) in all the analyzed MV genomes.
Mutations occurring within intergenic regions.
▼28 nt 2773
▼8 nt 18224
Δ 16 nt (2773-2788)
Δ 16 nt (2773-2788)
Δ 16 nt (2773-2788)
Δ 28 nt (2773-2800)
Δ 16nt (18224-18239)
Mutations detected in TIR genesa.
Mutations detected in centrally located genes.
Δ 10nt (11939-11948)
Mutations detected in centrally located genes continued.
Sequence analysis of intergenic regions
The 7 intergenic regions analyzed corresponded to those preceding the ORFs M002, M004.1, M005, M008.1, M017, M122 and M144. Sequence data from all the MV strains investigated showed that the regions prior to ORFs M004.1, M005 and M122 did not have any mutations and only those preceding ORFs M002, M008.1, M017 and M144 had changes (Table 2) in some of the MV isolates.
The intergenic regions upstream of ORFs M008.1 and M144 were rather conserved in most MV strains and contained only single nucleotide point mutations in strains 87 and 4604 (Table 2).
Sequence analysis of genes from within the TIRs
Considering the previous description of mutations in field strains as well as the virulence factor coding genes within the MV genome TIRs we decided to include three fragments from this region of the genome. For this purpose we designed three pairs of specific oligonucleotide primers (Table 1) which allowed the analysis of the full or partial sequences of 5 repeated genes (M002L/R, M004L/R, M004.1L/R, M005L/R, M007L/R) from within the TIRs (Table 3). For clarity only the coordinates of changes occurring in the L-TIR genes are indicated in the description (the numbering corresponds to the MV Lu genome GenBank accession number AF170726).
The M002 ORF sequence was conserved in six field isolates with respect to that of reference Lu strain. Strains 1312 and 7411 had nonsynonymous mutations at positions 2219 and 2393, affecting amino acid residues 143 and 85 of the corresponding protein products, respectively (Table 3). It should be mentioned that two different nonsynonymous mutations were also observed within this ORF (nt. 2497 and 2594) in the previously sequenced 6918 strain giving rise to non conservative amino acid substitutions at positions 18 and 50 (Table 3). In contrast to the reasonable conservation of this ORF in most of the studied field strains the 2788 isolate contained a single nucleotide insertion at position 2600 which led to a change in the amino acid sequence of the M002 ORF product from residue 18 onwards and to its truncation after residue 28 (Table 3).
Previous studies from our laboratory detected an Mlu I RFLP in several strains which mapped to the M004/M004.1/M005 genomic region (data not shown). The strategy used for sequencing of the entire M004.1L/R gene (Table 1) also led to partial amplification and sequencing of the M004L/R and M005L/R genes. In this region 7 different point mutations were observed in 7 of the 9 strains analysed (Table 3). Two isolates (4604 and 7514) did not have any changes with respect to reference strain Lu in the entire amplified M004/M004.1/M005 genomic region. This was also the case for the previously described strain 6918 although this last isolate had a C5009T mutation which mapped within ORF M005, outside the region sequenced in the present study. Strain 7411 contained only a silent mutation (C4412T) and isolates 466 and 2012 a nonsynonymous mutation (G4457C; N60K) in the sequenced M004 fragment. Four isolates (86, 87, 466 and 2012) contained a common nonsynonymous mutation (C4937T; A483T) in the sequenced M005 fragment, which led to the afore mentioned Mlu I RFLP (data not shown). In the fully sequenced ORF M004.1, isolates 87 and 86 shared two mutations one silent (G4754A) and one nonsynonymous (A4750G; F46L) whereas isolates 2788 and 1312 contained two other synonymous mutations (G4715A and G4775A respectively) not present in any of the other MV strains studied.
In the M007 gene most studied field strains (86, 466, 2012, 4604, 7411 and 7514) did not have mutations with respect to reference strain Lu. However, strains 87, 1312 and 2788 contained an identical nonsynonymous mutation (T8394C; Q128R) (Table 3), while strain 1312 contained a further silent mutation (G8456T) in this genomic region (Table 3). It should be mentioned that the published sequence of strain 6918  also showed the presence of a nonsynonymous mutation (G8064A; S238F) within the M007 gene (Table 3).
Sequence analysis of centrally located genes
In order to investigate putative changes in unique genes located in the central part of MV genome fifteen genes (M009L, M010L, M011L, M017L, M034L, M036L, M069L, M071L, M121R, M122R, M130R, M135R, M141R, M144R and M148R) were selected for PCR amplification using specific primers (Table 1) and nucleotide sequencing. Additional primers used for the sequencing of genes M009L, M036L and M148R are shown in Additional file 3. Five of these genes (M034L, M069L, M071L, M130R and M135R) were identical in the regions sequenced (data not shown) in all the analyzed MV genomes.
Four strains contained mutations in the M009 gene (Table 4). Strains 7514, 7411 and 4604 contained nonsynonymous point mutations at different positions, while strain 1312 contained a two-nucleotide insertion which led to disruption and truncation of the predicted ORF (Table 4). The analysis of the published M009L sequence from 6918 strain  showed the presence of a nonsynonymous point mutation (C12293A; G280C) and a 10 nt deletion which promoted a frame shift after amino acid residue 395 (Table 4).
Six genes of this central genome area (M010L, M011L, M121R, M122R, M141R and M144R) showed a low number of changes in some of the investigated strains (Tables 4 and 5). M121 had a single point mutation (C115910A; S21Y) in strains 2788 and 4604. M122 contained a single silent mutation (G116436A) in strain 2788. The M010L gene was conserved in all strains studied except for the 2788 isolate which contained two nonsynonymous mutations. M011L showed a single synonymous mutation which was shared by strains 2788 and 4604.
In the M141 region strains 87 and 86 contained a single silent mutation (T137666C) and strain 7514 a single nonsynonymous mutation (G137487A; R140Q). Strains 7514 and 7411 contained different nonsynonymous mutations within the coding region of M144 while strains 7411 and 4604 shared a nonsynonymous mutation (C140143T; R245C) in this gene. Strain 1312 was the only other strain to show a mutation in this region (C140154T).
Gene M148R showed sequence changes in most of the investigated strains, except for isolate 1312. M148 contained single nonsynonymous mutations in strains 86, 87, 466, 2012 and 4604 while three other isolates (2788, 7514, and 7411) showed two changes, a silent and a nonsynonymous mutation (Table 5). In the published 6918 sequence  M148R showed the presence of a silent mutation and a single nucleotide deletion (C142964) which promoted a frame shift.
Gene M017L which was conserved in most of the studied strains, contained insertions or deletions in three of the field isolates at genome position 18008 following a homopolymeric stretch of 8 thymidine residues. Strains 2788 and 4604 contained dithymidine insertions and strain 7411 contained a single thymidine deletion all promoting frame shifts and truncation of the resulting gene product (Table 4).
The M036L gene contained mutations in all nine strains studied when compared to the Lu published sequence. A single nonsynonymous mutation (T38822C) was present in 8 of the 9 strains, with strain 7411 the only strain not to present this mutation. Three strains (1312, 4604 and 7411) contained different synonymous mutations in this region and strain 7411 showed a nonsynonymous mutation (G39097A; A52V).
Two homopolymeric stretches within gene M036 were sites of multiple insertion or deletion mutations. Following a 7 nt homopolymeric stretch of thymidines, at base number 39162, three types of insertion were observed. Strains 87, 86 and 4604 contained single thymidine insertions, strains 466, 2012 and 7514 contained an insertion of three thymidines while strain 1312 contained an insertion of two thymidine residues. Following a guanosine homopolymeric stretch of 6 nts two strains (87 and 86) had single guanosine insertions (position 38274), while strain 1312 contained a single guanosine deletion (ΔG38274). The effects on the predicted ORF lengths of these insertions and deletions have on M036 are described in the footnote in Table 4.
Since the deliberate release of MV in Australia in 1950 and France in 1952 the emergence of more resistant hosts and the adaptation of virus strains has been well documented [25, 26]. However, few studies have addressed the sequence changes that have occurred in the MV genome during this period [1, 6, 8, 9] or more specifically the sequence changes involved in virus attenuation. Analysis of the molecular biology of MV in Australia have identified mutations in field strains  which have been used to study archived MV isolates and to track virus spread in the field [6, 11]. Although attenuated strains were detected no correlation between the observed RFLPs and virulence was described. With the exception of the sequencing of the avirulent strain 6918  and recent analyses of virulent MV circulating in Portugal and Spain [1, 9] extensive studies on the molecular biology of European strains of MV are lacking, with sequence analysis concentrated on a single short fragment (491 nts) of the M022 envelope protein gene [3, 4].
In order to bridge this gap in our understanding of the biology of MV we set out to molecularly characterise nine strains of MV isolated in Spain between the years 1992 and 1995. These strains were from wide ranging geographic locations from throughout Spain and had been previously graded for virulence by experimental infection of rabbits, and were chosen because they represent viruses with markedly different levels of attenuation .
To carry out epidemiological studies of MV it is essential to be able to differentiate between virus strains. Experimental infection of rabbits is not a suitable method for large scale continuous MV monitoring, therefore molecular characterisation of strains is preferable.
Using the mutations detected in this study the majority of the virus strains could be differentiated from one another. Despite a very high degree of sequence conservation, variable hotspots (regions containing M004L/R, M036L and M148R) in the genome were detected that could be used to provide phylogenetic data. We have not included a phylogenetic analysis using these fragments as the number of samples analysed was small (n = 9). However, the genetic relatedness of several strains could be inferred from shared mutations. In particular strains 466 and 2012, both virulence grade A  could not be differentiated from each other and shared 7 mutations with respect to the Lu sequence. Several strains also shared multiple mutations e.g. strains 87 and 86, and strains 2788 and 4604. These results may indicate that particular strains are derived from others or that the sites and type of mutations observed occur frequently. It is likely that some of the mutations arise frequently and revert showing the dynamic nature of the virus in the field. Further work will be required to determine if the mutations described are stable at the population level. Interestingly, the strains most related to each other originate in regions separated by between 500 and 1000 km (see Additional file 1). This observation is likely the consequece of movement of wild rabbits for repopulation of areas  rather than examples of convergent evolution.
The grossest changes were observed in the intergenic regions analysed. Deletions and insertions of tandem repeat sequences were common and have been reported in the Australian field studies . These mutations are likely to be too frequent to be useful in phylogenetic studies.
With the exception of M036L, the highest numbers of mutations were observed in the terminal regions. Strains 87, 466, 2012 and 86 (all virulence grade A) contained numerous mutations in the TIRs and immediately flanking regions. Only strains 87 and 86 shared a further synonymous mutation in the central genome located in the M141R gene. However, the viruses in which we observed the highest numbers of mutations in the central regions were viruses that had reduced virulence grades when compared to Lu . Strains 2788, 7514, 1312 (all grade B), 7411 (grade C) and 4604 (grade E) all contained mutations to genes in the central more conserved region of the genome. The presence of these mutations is surely indicative of the presence of more mutations yet to be detected, the cumulative effect of which may explain the attenuation of these strains.
In strain 6918 eighty mutations with respect to Lu were observed  however, it is not yet known which are responsible for the virus attenuation. Five 6918 genes carried mutations that disrupted ORFs (M009L, M036L, M069R, M135R and M148R). When the mutations found in the nine strains studied here and the strain 6918 are compared none were common. However, our data may provide insights into the reasons for virus attenuation of some of the nine strains analysed. Four genes contained mutations that disrupted ORFs, M002L/R, M009L, M036L and M017L.
M002 (previously termed MT-2) is a tumor necrosis factor receptor homolog with immunomodulatory functions ; reviewed by . Inactivation studies have shown that M002 is a virulence factor . Strain 2788 contained an insertion that disrupted the M002 ORF, and was somewhat but not completely attenuated with respect to Lu (strain 2788 is virulence grade B). While the analysis of individual genes may give us clues to the virulence of particular strains it is clear that factors such as compensatory mutations complicate the study of attenuation of viruses with large genomes.
While the function of M036 is unknown, disruptions to the M036 ORF occur in virulent ( and this work) and attenuated strains ( and this work) so it is unlikely that this mutation has an effect on virulence. It is clear that although the full gene product is not necessary for virus replication, it is maintained in the virus genome and therefore may offer variable regions to target to obtain phylogenetic data.
The M009L gene forms part of the interesting family of Kelch-like proteins represented in MV Lu genome by five genes (M006L/R, M008L/R, M009L, M014L and M140R) 3 as single copies and 2 duplicated at the left and right TIR. The M009 ORF is disrupted in the attenuated strain 6918  and strain 1312. Morales et al., (2008) argue that this mutation is unlikely to be a critical virulence factor. In the study presented here, M009L was observed to contain a dinucleotide insertion that disrupted the ORF in strain 1312 and in virulence studies strain 1312 showed a somewhat reduced virulence (grade B, ) but was lethal in all rabbits infected. This could confirm that this ORF does not act as a critical virulence factor, however, until the appropriate knockout viruses are constructed and tested it cannot be ruled out that this protein plays some role in virulence.
The function of M017L is unknown. Nevertheless, considering the truncation of this ORF in strains 2788 and 4604 which showed reduced or complete lack of virulence respectively it is tempting to speculate that the truncation of this ORF, when coupled with the other mutations observed, may have an effect on virulence. Further work will be required to obtain the full-genome sequences and elucidate the exact role of the M017 protein in the virus life cycle.
It is unlikely that we have identified all the mutations responsible for the attenuation of the strains 7411 and 4604, virulence grades C and E respectively. Preliminary RFLP analysis of full-length genomes and TIRs amplified by long range PCR showed that no large deletions in the genomes of these viruses had occurred (data not shown). It is therefore likely that attenuation is due to the accumulation of point mutations and only full genome sequencing coupled with mutational analysis will show why these strains are less virulent.
Interestingly the most attenuated strain used in the study was strain 4604 which was isolated from the same region as strain 87, the most virulent isolate studied. No common mutations were identified between these strains in this study indicating that there are likely to be genetically distinct strains circulating in any one region. Repeated sampling will be required to show which strains predominate at present.
One of the most striking questions about the biology of MV is why should attenuated MV strains arise? The attenuation of some of the Spanish isolates may reflect a necessity for a tendency toward attenuation in geographical locations that had low density rabbit populations at the time of virus isolation . Strains 7514, 1312 and 7411 all come from regions with low density wild rabbit populations. As MV has no other natural reservoir other than the European rabbit longer survival times in infected rabbits will increase the likelihood of encountering a new host or vectors in smaller populations. This is one aspect of virus/host evolution that could be examined using phylogenetic studies of MV isolates in Spain.
In summary, the data included in this study provide an insight into the mechanisms of attenuation of MV strains and indicates useful targets for use in phylogenetic and epidemiological studies. The genes M004L/R, M036L and M148R were shown to contain variable sequences and can be considered possible targets for genetic relatedness studies. Using the type of data obtained in this study it will be possible to identify the types of virus circulating in an epidemic or outbreak, determine if new virus types are emerging or if one virus type is predominating in a particular area and be able to track the spread of these virus types.
Cells and virus
The nine MV strains used in this study were previously described and characterised for virulence in rabbits  (See Additional file 2). Each strain is identified by a number (assigned by ), region of origin in Spain (see Additional file 1) and virulence grade as follows: 87/Lleida/A, 466/Valencia/A, 2012/Asturias/A, 86/Badajoz/A, 2788/Albacete/B, 7514/Pontevedra/B, 1312/LaRioja/B, 7411/Canarias/C and 4604/Lleida/E. For simplicity, each strain is referred to by its identification number only from this point onwards. It should be mentioned that although strain 6918/Girona/E was not directly analyzed in this study the corresponding genome sequences from this virus isolate were also included in the analyses performed, together with the reference strain Lausanne (Lu).
Myxoma virus Lu strain and the nine field isolates listed above were grown and titered in RK13 cells which were maintained in Dulbecco's-modified Eagle medium (DMEM (Gibco, Carlsbad, CA)) supplemented with 10% foetal calf serum (FCS - PAA laboratories, UK) and 40 mg/L gentamicin (Gibco, Carlsbad, CA). To avoid the accumulation of mutations associated with virus adaptation to tissue culture the MV isolates were not passaged more than 3 times prior to genomic RFLP studies and were not passaged more than once for genome sequencing studies.
MV DNA purification
For preliminary RFLP studies using full-length viral genomes we used the hypotonic burst method to rupture cells followed by PEG precipitation of virions as described previously . Partially purified virions were treated with DNaseI (15 units, 1 h, 37°C; Fermentas). DNA was extracted from precipitated virions using a commercial kit (Masterpure™ Complete DNA and RNA purification kit, Epicentre® Biotechnologies), following the total DNA purification protocol.
To obtain viral DNA for PCR and sequencing studies, total DNA was extracted from infected RK13 cell monolayers using the QIAamp DNA mini kit (QIAGEN, Hilden, Germany) as per the manufacturer's instructions.
The long-range PCR used for the detection of RFLPs in the TIR regions was previously described . The oligonucleotides used for the PCR amplification of the MV genomic regions for sequence analysis are shown in Table 1. Additional primers used for the sequencing of genes M009L, M036L and M148R are shown in Additional file 3. The genes that were completely or partially sequenced were distributed (Additional file 4) along the full MV genome including both at right and left TIR and within the central not repeated sequences.
Cycle conditions were as follows; 94°C 2 min, then 35 cycles of 94°C 30 seconds, 55°C 30 seconds and 68°C 30 sec-2 min, with a final extension of 5-10 min at 68°C. Reactions were carried out using TaKaRa LA Taq (Takara, Madison, WI) in 1 × reaction buffer, 2.5 mM MgCl2, 2.5 mM of each dNTP, 2.5 units of enzyme and 0.2 μM of each oligonucleotide.
DNA analysis, gels and software
Agarose (SeaKem Gold Agarose [Lonza, Basel, Switzerland]) gels (0.75%) in 0.04 M Tris, 1.14% acetic acid and 0.002 M EDTA (TAE) were run at room temperature and stained with ethidium bromide or with 1 × SYBR green stain (Invitrogen, Carlsbad, CA).
PCR reaction products were analysed by agarose gel electrophoresis. Full size PCR products were cut from gels using alcohol cleaned scalpel blades and purified using the Wizard SV gel and PCR clean-up system (Promega, Madison, WI, USA). Purified PCR products or MV genomic DNA were quantified on agarose gels by comparison with quantified DNA markers (GenerulerPlus, Takara, Madison, WI) and either subjected to digestions using a variety of restriction enzymes (as per manufacturer's instructions) for RFLP studies or 50 ng of DNA were mixed with 10 μM of the appropriate oligonucleotide and sequenced.
Agarose gels were photographed using the Gel logic 200I system, and images were analysed with Kodak Molecular Imaging software (Version 4), Kodak (NY, U.S.A).
An ABI PRISM® 3130×l Genetic Analyzer (Sequencing services, Universidad de Oviedo) was used to sequence all gel purified PCR products and Chromas LITE freeware (Version 2.01- http://www.technelysium.com.au) was used to analyse sequences and to convert data to text format for subsequent alignment analysis.
Vector NTi version 11 (Invitrogen, Carlsbad, CA) software was used for all alignment analysis. The full-length sequences for Lu and strain 6918 were obtained from the NCBI database with the accession numbers AF170726 and EU552530 respectively.
We thank A. Pagès-Manté for providing the virus strains used in this study. We also gratefully acknowledge Rebeca Alvarez Garcia and José Luis Martínez Fernández at the Universidad de Oviedo sequencing services. This work was supported in part by Ministerio de Medio Ambiente y Medio Rural y Marino, INTERCUN and by the INIA grant FAU2006-00214-CO2-01 cofinanced by FEDER.
- Muller A, Silva E, Abrantes J, Esteves PJ, Ferreira PG, Carvalheira JC, Nowotny N, Thompson G: Partial sequencing of recent Portuguese myxoma virus field isolates exhibits a high degree of genetic stability. Vet Microbiol 2010, 140: 161-166. 10.1016/j.vetmic.2009.07.028PubMedView ArticleGoogle Scholar
- Marlier D, Herbots J, Detilleux J, Lemaire M, Thiry E, Vindevogel H: Cross-sectional study of the association between pathological conditions and myxoma-virus seroprevalence in intensive rabbit farms in Europe. Prev Vet Med 2001, 48: 55-64. 10.1016/S0167-5877(00)00177-XPubMedView ArticleGoogle Scholar
- Farsang A, Makranszki L, Dobos-Kovacs M, Virag G, Fabian K, Barna T, Kulcsar G, Kucsera L, Vetesi F: Occurrence of atypical myxomatosis in Central Europe: clinical and virological examinations. Acta Veterinaria Hungarica 2003, 51: 493-501. 10.1556/AVet.51.2003.4.7PubMedView ArticleGoogle Scholar
- Kritas SK, Dovas C, Fortomaris P, Petridou E, Farsang A, Koptopoulos G: A pathogenic myxoma virus in vaccinated and non-vaccinated commercial rabbits. Res Vet Sci 2008, 85: 622-624. 10.1016/j.rvsc.2008.03.008PubMedView ArticleGoogle Scholar
- Kerr PJ, Best SM: Myxoma virus in rabbits. Rev Sci Tech 1998, 17: 256-268.PubMedGoogle Scholar
- Saint KM, French N, Kerr P: Genetic variation in Australian isolates of myxoma virus: an evolutionary and epidemiological study. Arch Virol 2001, 146: 1105-1123. 10.1007/s007050170109PubMedView ArticleGoogle Scholar
- Labudovic A, Perkins H, van Leeuwen B, Kerr P: Sequence mapping of the Californian MSW strain of Myxoma virus. Arch Virol 2004, 149: 553-570. 10.1007/s00705-003-0222-6PubMedView ArticleGoogle Scholar
- Morales M, Ramirez MA, Cano MJ, Parraga M, Castilla J, Perez-Ordoyo LI, Torres JM, Barcena J: Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain. J Virol 2009, 83: 2397-2403. 10.1128/JVI.02189-08PubMedPubMed CentralView ArticleGoogle Scholar
- Alda F, Gaitero T, Suarez M, Doadrio I: Molecular characterisation and recent evolution of myxoma virus in Spain. Arch Virol 2009, 154: 1659-1670. 10.1007/s00705-009-0494-6PubMedView ArticleGoogle Scholar
- Fenner F, Marshall ID: A comparison of the virulence for European rabbits (Oryctolagus cuniculus) of strains of myxoma virus recovered in the field in Australia, Europe and America. J Hyg (Lond) 1957, 55: 149-191.View ArticleGoogle Scholar
- Kerr PJ, Merchant JC, Silvers L, Hood GM, Robinson AJ: Monitoring the spread of myxoma virus in rabbit Oryctolagus cuniculus populations on the southern tablelands of New South Wales, Australia. II. Selection of a strain of virus for release. Epidemiol Infect 2003, 130: 123-133. 10.1017/S0950268802007860PubMedPubMed CentralView ArticleGoogle Scholar
- Cameron C, Hota-Mitchell S, Chen L, Barrett J, Cao JX, Macaulay C, Willer D, Evans D, McFadden G: The complete DNA sequence of myxoma virus. Virology 1999, 264: 298-318. 10.1006/viro.1999.0001PubMedView ArticleGoogle Scholar
- Barcena J, Pages-Mante A, March R, Morales M, Ramirez MA, Sanchez-Vizcaino JM, Torres JM: Isolation of an attenuated myxoma virus field strain that can confer protection against myxomatosis on contacts of vaccinates. Arch Virol 2000, 145: 759-771. 10.1007/s007050050669PubMedView ArticleGoogle Scholar
- Everett H, Barry M, Lee SF, Sun X, Graham K, Stone J, Bleackley RC, McFadden G: M11L: a novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J Exp Med 2000, 191: 1487-1498. 10.1084/jem.191.9.1487PubMedPubMed CentralView ArticleGoogle Scholar
- Wang G, Barrett JW, Nazarian SH, Everett H, Gao X, Bleackley C, Colwill K, Moran MF, McFadden G: Myxoma virus M11L prevents apoptosis through constitutive interaction with Bak. J Virol 2004, 78: 7097-7111. 10.1128/JVI.78.13.7097-7111.2004PubMedPubMed CentralView ArticleGoogle Scholar
- Cameron CM, Barrett JW, Liu L, Lucas AR, McFadden G: Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo. J Virol 2005, 79: 6052-6067. 10.1128/JVI.79.10.6052-6067.2005PubMedPubMed CentralView ArticleGoogle Scholar
- Duteyrat JL, Gelfi J, Bertagnoli S: Ultrastructural study of myxoma virus morphogenesis. Arch Virol 2006, 151: 2161-2180. 10.1007/s00705-006-0791-2PubMedView ArticleGoogle Scholar
- Su J, Wang G, Barrett JW, Irvine TS, Gao X, McFadden G: Myxoma virus M11L blocks apoptosis through inhibition of conformational activation of Bax at the mitochondria. J Virol 2006, 80: 1140-1151. 10.1128/JVI.80.3.1140-1151.2006PubMedPubMed CentralView ArticleGoogle Scholar
- Barrett JW, Sypula J, Wang F, Alston LR, Shao Z, Gao X, Irvine TS, McFadden G: M135R is a novel cell surface virulence factor of myxoma virus. J Virol 2007, 81: 106-114. 10.1128/JVI.01633-06PubMedPubMed CentralView ArticleGoogle Scholar
- Adams MM, van Leeuwen BH, Kerr PJ: Construction and evaluation of live attenuated myxoma virus vaccines with targeted virulence gene deletions. Vaccine 2008, 26: 5843-5854. 10.1016/j.vaccine.2008.08.036PubMedView ArticleGoogle Scholar
- Barrett JW, Werden SJ, Wang F, McKillop WM, Jimenez J, Villeneuve D, McFadden G, Dekaban GA: Myxoma virus M130R is a novel virulence factor required for lethal myxomatosis in rabbits. Virus Res 2009, 144: 258-265. 10.1016/j.virusres.2009.05.009PubMedView ArticleGoogle Scholar
- Opgenorth A, Graham K, Nation N, Strayer D, McFadden G: Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J Virol 1992,66(8):4720-31.PubMedPubMed CentralGoogle Scholar
- Blanié S, Mortier J, Delverdier M, Bertagnoli S, Camus-Bouclainville C: M148R and M149R are two virulence factors for myxoma virus pathogenesis in the European rabbit. Vet Res 2009, 40: 11. Epub 2008 Nov 19 10.1051/vetres:2008049PubMedPubMed CentralView ArticleGoogle Scholar
- Dalton KP, Ringleb F, Martin Alonso JM, Parra F: Rapid identification of myxoma virus variants by long-range PCR and restriction fragment length polymorphism analysis. J Virol Methods 2009, 161: 284-288. 10.1016/j.jviromet.2009.06.026PubMedView ArticleGoogle Scholar
- Fenner F, Poole WE, Marshall ID, Dyce AL: Studies in the epidemiology of infectious myxomatosis of rabbits. VI. The experimental introduction of the European strain of myxoma virus into Australian wild rabbit populations. J Hyg (Lond) 1957, 55: 192-206.View ArticleGoogle Scholar
- Best SM, Kerr PJ: Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits. Virology 2000, 267: 36-48. 10.1006/viro.1999.0104PubMedView ArticleGoogle Scholar
- Delibes-Mateos M, Ramírez E, Ferreras P, Villafuerte R: Translocations as a risk for the conservation of European wild rabbit Oryctolagus cuniculus lineages. Oryx 2008, 42: 259-264. 10.1017/S0030605308006984View ArticleGoogle Scholar
- Upton C, Macen JL, Schreiber M, McFadden G: Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 1991, 184: 370-382. 10.1016/0042-6822(91)90853-4PubMedView ArticleGoogle Scholar
- Zuniga MC: A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation. Virus Res 2002, 88: 17-33. 10.1016/S0168-1702(02)00118-1PubMedView ArticleGoogle Scholar
- Villafuerte R, Viñuela J, Blanc JC: Extensive predator persecution caused by population crash in a game species: The case of red kites and rabbits in Spain. Biological conservation 1998, 84: 181-188. 10.1016/S0006-3207(97)00094-3View ArticleGoogle Scholar
- Dalton KP, Ringleb F, Martin Alonso JM, Parra F: Rapid purification of myxoma virus DNA. J Virol Methods 2009, 162: 284-287. 10.1016/j.jviromet.2009.08.003PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.